Cover of: Decision making in drug research | Read Online

Decision making in drug research

  • 870 Want to read
  • ·
  • 62 Currently reading

Published by Raven Press in New York .
Written in English


  • Drugs -- Research -- Decision making.,
  • Research -- Methods -- Congresses.,
  • Drug screening -- Congresses.,
  • Drug industry -- Congresses.,
  • Decision making -- Congresses.

Book details:

Edition Notes

Statementeditor, Franz Gross, with the assistance of T.B. Binns and Susi R. Naegeli.
ContributionsGross, F. H., Binns, T. B., Naegeli, Susi R., Smith Kline Foundation.
LC ClassificationsRS122 .D43 1983
The Physical Object
Paginationxii, 244 p. :
Number of Pages244
ID Numbers
Open LibraryOL3169111M
ISBN 100890049440
LC Control Number83011210

Download Decision making in drug research


Berman’s Pediatric Decision Making uses an algorithmic, structured approach to lead you to the right diagnosis and treatment every time. Drs. Lalit Baja, Simon Hambidge, Ann-Christine Nyquist, and Gwendolyn Kerby use evidence-based research and flow charts for each presenting complaint or specific disorder to provide quick access to the information you need for effective decision making.   Decision-making is a core function of any drug development firm. Developing drugs demands a firm to be highly innovative, while at the same time the activity is strictly regulated. Successful drug development offers the right to apply for a long-term patent that confers exclusive marketing rights Cited by: National Research Council and Institute of Medicine. A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration. Washington, DC: The National Academies Press. doi: / This book offers a high-level treatise of evidence-based decisions in drug development. Because of the inseparable relationship between designs and decisions, a good portion of this book is devoted to the design of clinical trials. The book begins with an overview of product development and.

The book offers useful insights to statisticians, clinicians, regulatory affairs managers and decision-makers in the pharmaceutical industry who have a basic understanding of the drug-development process and the clinical trials conducted to support drug-marketing by: 1.   Activity in decision-making brain regions of people who use recreational stimulants predicts who will discontinue use and who will develop a drug use disorder, according to a new study led by Martin Paulus, PhD, of Laureate Institute of Brain Research, Tulsa, Oklahoma.. The study, which appears in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, measured brain activity . A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration describes the proposed risk-characterization framework that can be used to evaluate, compare, and communicate the public-health consequences of decisions concerning a wide variety of products. The framework presented in this report is intended to. I. Drug Abuse and Addiction As a result of scientific research, we know that addiction is a disease that affects both the brain and behavior. We have identified many of the critical to judgment, decision making, learning and memory, and behavior control.7Scientists believe that these changes alter.

Designed to facilitate the diagnostic and therapeutic decision-making process, this book consists of comprehensive algorithmic decision trees that guide readers through more than disorders. Brief text accompanies each algorithm and explains the key steps of the decision-making process. The previous edition was published in Cited by: 7. Additional research may also clarify how personal experience within drug discovery and development influences judgment and help to optimize decision outcomes in the drug development sector. The development of a new drug is an extremely high-risk enterprise. The attrition rates of development projects and the average costs for each launched product are daunting, and the completion of a development program requires a very long time horizon. These facts imply that there are huge potential gains, should one be able to improve efficiency and enhance decision-making : Stig Johan Wiklund.   Research output: Book/Report › Book. it considers neurodevelopmental and clinical aspects of these issues, for example the role of decision making and reward in drug addiction. It also looks at the applied aspects of this knowledge to other disciplines, including the growing field of Neuroeconomics. Decision Making, Affect, and Cited by: